COVID-19 Vaccine Not Associated With Birth Defects Detectable on Ultrasound Findings fill gap left vacant when pregnant people were excluded from the initial trials. Scientists…
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and search identifier NCT05289037 for a list of sites and contacts….
Revolutionary tool will meet future pandemics with accelerated response. A new tool speeds up development of vaccines and other pharmaceutical products by more than one…
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies. While many people in wealthier countries have been…
A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence…
First comprehensive trial in patients with impaired immunity shows that mRNA-based Covid-19 vaccines are well tolerated. Spare a thought for patients with impaired immunity during…
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand rare but potentially serious systemic…
Researchers call for routine monitoring of vaccine effectiveness as the covid-19 pandemic continues to evolve. mRNA vaccines are highly effective in preventing covid-19 associated hospital…
Kaiser Permanente study shows 3 doses of Moderna COVID-19 vaccine highly effective against hospitalization from omicron or delta. New Kaiser Permanente research published on February…
Two large studies carried out independently in the UK both found a slight increase in risk of intracranial thromboses in some populations after the AstraZeneca…
Data also show people who are Hispanic or Black half as likely to receive booster than people who are white. A nationwide study from the…
Cholera, a diarrheal disease caused by the highly transmissible bacteria Vibrio cholerae, kills tens of thousands of people each year worldwide. Current vaccines last only 2–5…
A molecule developed by researchers at the University of Helsinki can inactivate the coronavirus spike protein and offers effective short-term protection against the virus. Cell…
Kaiser Permanente study assessed of Pfizer–BioNTech COVID-19 vaccine effectiveness against infection, hospitalization, and death up to 8 months after vaccination. A Kaiser Permanente study published…
Researchers also found that previously-infected patients with obesity, contrary to expectations, had a higher and more sustained immune response. New research to be presented at…
In mice, a vaccination strategy that uses an mRNA coronavirus vaccine injection followed by a nasal spray booster generates immune protection in the airways. A…
Despite experiencing the virus’s devastation firsthand, many health care workers did not intend to get vaccinated when the COVID-19 vaccinations became available. However, a recent Northwestern…
